Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
C Moret, I Pastrie, M Briley
Index: Methods Find. Exp. Clin. Pharmacol. 10(10) , 619-21, (1988)
Full Text: HTML
Abstract
3H-Quinuclidinyl benzylate (3H-QNB) and 3H-cis-methyldioxolane (3H-CD) binding to cholinergic muscarinic receptors have been carried out on the same membrane preparation from the rat brain cortex. Inhibition of 3H-QNB and 3H-CD binding by cholinergic muscarinic agonists and antagonists has been studied with determination of the IC50 values for each ligand. Antagonists were as potent at inhibiting 3H-QNB binding as 3H-CD binding. Muscarinic agonists were much less potent at inhibiting 3H-QNB binding than 3H-CD binding. The ratio of the IC50 values for the inhibition of the binding of 3H-QNB and 3H-CD was between 1 and 10 for antagonists and between 500 and 5000 for agonists. It is suggested that the determination of this ratio predicts agonist or antagonist activity of unknown compounds and represents a useful tool for their screening.
Related Compounds
Related Articles:
1987-08-01
[Mol. Pharmacol. 32(1) , 230-40, (1987)]
1987-04-01
[Naunyn Schmiedebergs Arch. Pharmacol. 335(4) , 372-7, (1987)]
Muscarinic M3 receptors mediate contractions in rabbit, endothelium-denuded aorta in vitro.
1994-08-01
[J. Auton. Pharmacol. 14(4) , 283-93, (1994)]
cis-Methyldioxolane specifically recognizes the m2 muscarinic receptor.
1994-01-01
[J. Neurochem. 62(1) , 388-91, (1994)]
Cholinergic antagonists and REM sleep generation.
1991-03-08
[Brain Res. 543(1) , 175-9, (1991)]